# FDA 483 - Ferring Pharmaceuticals Inc - March 14, 2023

Source: https://www.keypedia.com/records/483/ferring-pharmaceuticals-inc/048ba5ff-1130-486c-b9fc-17cc22a70b5a

> FDA 483 for Ferring Pharmaceuticals Inc on March 14, 2023. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Ferring Pharmaceuticals Inc
- Inspection Date: 2023-03-14
- Product Type: other
- Office Name: New Jersey District Office
- Summary: An FDA inspection of Ferring Pharmaceuticals Inc. in Parsippany, NJ, identified a significant issue regarding the monitoring of clinical studies. The firm failed to ensure proper oversight of investigational product storage, specifically noting unreported temperature deviations. This indicates a lapse in critical study monitoring practices.

## Related Documents

- [CRL - Unknown Date](https://www.keypedia.com/records/crl/ferring-pharmaceuticals-inc/9300a22b-156b-4792-a003-0c0f2901e15c)
- [CRL - Unknown Date](https://www.keypedia.com/records/crl/ferring-pharmaceuticals-inc/4e70322f-a828-4dda-a5fe-93bd49a040d3)

## Related Officers

- [investigator](https://www.keypedia.com/people/tyanna-n-hadley/8fdebfd7-d6f3-44ab-9dcb-864ab6d55d53)

Company: https://www.keypedia.com/companies/ferring-pharmaceuticals-inc/83aaeefd-d198-40f3-9192-71a8c408f5cf

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248